Marina Tuyishime

9PUBLICATIONS
61CO-AUTHORS
Innate immunityRegenerative medicine (incl. stem cells)Haematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 16, 2026
Antibodies against HLA-E-VL9 enhance NK cell and CD8+ T cell cytotoxicity against tumor cells and HIV-infected CD4+ T cells.

|Oct 29, 2025
Identifying correlates of viral rebound timing and viral control in SHIV-infected infant macaques after ART interruption.

Veronica Obregon-Perko, Achal Awasthi, Richard Barfield

|Apr 23, 2025
Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge.

Dieter Mielke, Marina Tuyishime, Natasha S Kelkar

|Jul 19, 2024
HLA-E-VL9 antibodies enhance NK cell and CD8 + T cell cytotoxicity against HIV-infected CD4 + T cells.

Joyce K Hwang, Daniel J Marston, Marina Tuyishime

|Nov 03, 2021
Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies.

Dieter Mielke, Sherry Stanfield-Oakley, Bhavesh Borate

|Aug 21, 2020
SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.

Amir Dashti, Chevaughn Waller, Maud Mavigner

Pageof 2

Frequent Collaborators

3 joint publications

Max Quastel

3 joint publications

Guido Ferrari

3 joint publications

Joyce K Hwang

2 joint publications

Maud Mavigner